Morphogens and blood-brain barrier function in health and disease

References

• Shen S, Zhang W. ABC transporters and drug efflux at the blood-brain barrier. Rev. Neurosci. 2010; 21(1):29-53; PMID:20458886
   PubMed Web of Science ®Google Scholar
• Spector R. Nutrient transport systems in brain: 40 years of progress. J. Neurochem. 2009; 111(2):315-20; PMID:19686385; http://dx.doi.org/10.1111/j.1471-4159.2009.06326.x
   PubMed Web of Science ®Google Scholar
• Wolburg H, Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 2002; 38(6):323-37; PMID:12529927; http://dx.doi.org/10.1016/S1537-1891(02)00200-8
   PubMed Web of Science ®Google Scholar
• Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006; 7(1):41-53; PMID:16371949; http://dx.doi.org/10.1038/nrn1824
   PubMed Web of Science ®Google Scholar
• Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H, Spellberg J, de la Pompa JL, Elia A, Wakeham A, Karan-Tamir B, et al. Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J. Immunol. 1999; 162(5):3022-30; PMID:10072554
   PubMed Web of Science ®Google Scholar
• Liu W-Y, Wang Z-B, Zhang L-C, Wei X, Li L. Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances. CNS Neurosci. Ther. 2012; 18(8):609-15; PMID:22686334; http://dx.doi.org/10.1111/j.1755-5949.2012.00340.x
   PubMed Web of Science ®Google Scholar
• Tietz S, Engelhardt B. Brain barriers: Crosstalk between complex tight junctions and adherens junctions. J. Cell Biol. 2015; 209(4):493-506; PMID:26008742; http://dx.doi.org/10.1083/jcb.201412147
   PubMed Web of Science ®Google Scholar
• Sá-Pereira I, Brites D, Brito MA. Neurovascular unit: a focus on pericytes. Mol. Neurobiol. 2012; 45(2):327-47; http://dx.doi.org/10.1007/s12035-012-8244-2
   PubMed Web of Science ®Google Scholar
• Daneman R. The blood-brain barrier in health and disease. Ann. Neurol. 2012; 72(5):648-72; PMID:23280789; http://dx.doi.org/10.1002/ana.23648
   PubMed Web of Science ®Google Scholar
• Engelhardt B. Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. J. Neurol. Sci. 2008; 274(1-2):23-6; PMID:18573502; http://dx.doi.org/10.1016/j.jns.2008.05.019
   PubMed Web of Science ®Google Scholar
• Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012; 33(12):579-89; PMID:22926201; http://dx.doi.org/10.1016/j.it.2012.07.004
   PubMed Web of Science ®Google Scholar
• De Vries HE, Blom-Roosemalen MCM, Oosten M van, de Boer AG, van Berkel TJ, Breimer DD, Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 1996; 64(1):37-43; PMID:8598388; http://dx.doi.org/10.1016/0165-5728(95)00148-4
   PubMed Web of Science ®Google Scholar
• Juhler M, Blasberg RG, Fenstermacher JD, Patlak CS, Paulson OB. A spatial analysis of the blood-brain barrier damage in experimental allergic encephalomyelitis. J. Cereb. Blood Flow Metab. 1985; 5(4):545-53; PMID:3877064; http://dx.doi.org/10.1038/jcbfm.1985.82
   PubMed Web of Science ®Google Scholar
• Lee D-H, Gold R, Linker RA. Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters. Int. J. Mol. Sci. 2012; 13(9):11783-803; PMID:23109883; http://dx.doi.org/10.3390/ijms130911783
   PubMed Web of Science ®Google Scholar
• Griot C, Vandevelde M, Richard A, Peterhans E, Stocker R. Selective degeneration of oligodendrocytes mediated by reactive oxygen species. Free Radic. Res. Commun. 1990; 11(4–5):181-93; PMID:1965721; http://dx.doi.org/10.3109/10715769009088915
   PubMed Web of Science ®Google Scholar
• Lakhan SE, Kirchgessner A, Tepper D, Leonard A. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front. Neurol. 2013; 4:32; PMID:23565108
   PubMed Web of Science ®Google Scholar
• Lassmann H, van Horssen J, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis. Nat. Rev. Neurol. 2012; 8(11):647-56; PMID:23007702; http://dx.doi.org/10.1038/nrneurol.2012.168
   PubMed Web of Science ®Google Scholar
• Carreiras MC, Mendes E, Perry MJ, Francisco AP, Marco-Contelles J. The multifactorial nature of Alzheimer's disease for developing potential therapeutics. Curr. Top. Med. Chem. 2013; 13(15):1745-70; PMID:23931435; http://dx.doi.org/10.2174/15680266113139990135
   PubMed Web of Science ®Google Scholar
• Ozawa Y. Neurodegenerative disease: Pieces of the Parkinson's puzzle. Nat. Rev. Neurosci. 2010; 11(12):787-787; PMID:21132875; http://dx.doi.org/10.1038/nrn2945
   PubMed Web of Science ®Google Scholar
• Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011; 7(11):639-49; PMID:21989247; http://dx.doi.org/10.1038/nrneurol.2011.153
   PubMed Web of Science ®Google Scholar
• Ashe HL, Briscoe J. The interpretation of morphogen gradients. Development 2006; 133(3):385-94; PMID:16410409; http://dx.doi.org/10.1242/dev.02238
   PubMed Web of Science ®Google Scholar
• Østerlund T, Kogerman P. Hedgehog signalling: how to get from Smo to Ci and Gli. Trends Cell Biol. 2006; 16(4):176-80; http://dx.doi.org/10.1016/j.tcb.2006.02.004
   PubMed Web of Science ®Google Scholar
• Patten I, Placzek M. The role of Sonic hedgehog in neural tube patterning. Cell. Mol. Life Sci. 2000; 57(12):1695-708; PMID:11130176; http://dx.doi.org/10.1007/PL00000652
   PubMed Web of Science ®Google Scholar
• Charron F, Stein E, Jeong J, McMahon AP, Tessier-Lavigne M. The Morphogen Sonic Hedgehog Is an Axonal Chemoattractant that Collaborates with Netrin-1 in Midline Axon Guidance. Cell 2003; 113(1):11-23; PMID:12679031; http://dx.doi.org/10.1016/S0092-8674(03)00199-5
   PubMed Web of Science ®Google Scholar
• Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, Terouz S, Sabbagh M, Wosik K, Bourbonnière L, Bernard M, et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 2011; 334(6063):1727-31; PMID:22144466; http://dx.doi.org/10.1126/science.1206936
   PubMed Web of Science ®Google Scholar
• Wang Y, Jin S, Sonobe Y, Cheng Y, Horiuchi H, Parajuli B, Kawanokuchi J, Mizuno T, Takeuchi H, Suzumura A. Interleukin-1β induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes. Kira J, ed. PLoS One 2014; 9(10):e110024; PMID:25313834; http://dx.doi.org/10.1371/journal.pone.0110024
   PubMed Web of Science ®Google Scholar
• Amankulor NM, Hambardzumyan D, Pyonteck SM, Becher OJ, Joyce JA, Holland EC. Sonic hedgehog pathway activation is induced by acute brain injury and regulated by injury-related inflammation. J. Neurosci. 2009; 29(33):10299-308; PMID:19692604; http://dx.doi.org/10.1523/JNEUROSCI.2500-09.2009
   PubMed Web of Science ®Google Scholar
• Xu QG, Midha R, Martinez JA, Guo GF, Zochodne DW. Facilitated sprouting in a peripheral nerve injury. Neuroscience 2008; 152(4):877-87; PMID:18358630; http://dx.doi.org/10.1016/j.neuroscience.2008.01.060
   PubMed Web of Science ®Google Scholar
• Mastronardi FG, daCruz LAG, Wang H, Boggs J, Moscarello MA. The amount of sonic hedgehog in multiple sclerosis white matter is decreased and cleavage to the signaling peptide is deficient. Mult. Scler. 2003; 9(4):362-71; PMID:12926841; http://dx.doi.org/10.1191/1352458503ms924oa
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dong W, Guo S, Zhao S, He S, Zhang L, Tang Y, Wang H. Lentivirus-mediated delivery of sonic hedgehog into the striatum stimulates neuroregeneration in a rat model of Parkinson disease. Neurol. Sci. 2014; 35(12):1931-40; PMID:25030123; http://dx.doi.org/10.1007/s10072-014-1866-6
   PubMed Web of Science ®Google Scholar
• Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002; 108(6):837-47; PMID:11955436; http://dx.doi.org/10.1016/S0092-8674(02)00685-2
   PubMed Web of Science ®Google Scholar
• Maniatis T. A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. Genes Dev. 1999; 13(5):505-10; PMID:10072378; http://dx.doi.org/10.1101/gad.13.5.505
   PubMed Web of Science ®Google Scholar
• Buscarlet M, Stifani S. The “Marx” of Groucho on development and disease. Trends Cell Biol. 2007; 17(7):353-61; PMID:17643306; http://dx.doi.org/10.1016/j.tcb.2007.07.002
   PubMed Web of Science ®Google Scholar
• Joksimovic M, Patel M, Taketo MM, Johnson R, Awatramani R. Ectopic Wnt/beta-catenin signaling induces neurogenesis in the spinal cord and hindbrain floor plate. PLoS One 2012; 7(1):e30266; PMID:22276170; http://dx.doi.org/10.1371/journal.pone.0030266
   PubMedGoogle Scholar
• Tang M, Villaescusa JC, Luo SX, Guitarte C, Lei S, Miyamoto Y, Taketo MM, Arenas E, Huang EJ. Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons. J. Neurosci. 2010; 30(27):9280-91; PMID:20610763; http://dx.doi.org/10.1523/JNEUROSCI.0860-10.2010
   PubMed Web of Science ®Google Scholar
• Gulacsi AA, Anderson SA. Beta-catenin-mediated Wnt signaling regulates neurogenesis in the ventral telencephalon. Nat. Neurosci. 2008; 11(12):1383-91; PMID:18997789; http://dx.doi.org/10.1038/nn.2226
   PubMed Web of Science ®Google Scholar
• Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, Barres BA. Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 2009; 106(2):641-6; PMID:19129494; http://dx.doi.org/10.1073/pnas.0805165106
   PubMed Web of Science ®Google Scholar
• Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, Reis M, Felici A, Wolburg H, Fruttiger M, et al. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J. Cell Biol. 2008; 183(3):409-17; PMID:18955553; http://dx.doi.org/10.1083/jcb.200806024
   PubMed Web of Science ®Google Scholar
• Inestrosa N, De Ferrari GV, Garrido JL, Alvarez A, Olivares GH, Barría MI, Bronfman M, Chacón MA. Wnt signaling involvement in beta-amyloid-dependent neurodegeneration. Neurochem. Int. 2002; 41(5):341-4; PMID:12176076; http://dx.doi.org/10.1016/S0197-0186(02)00056-6
   PubMed Web of Science ®Google Scholar
• Inestrosa NC, Toledo EM. The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease. Mol. Neurodegener. 2008; 3:9; PMID:18652670; http://dx.doi.org/10.1186/1750-1326-3-9
   PubMed Web of Science ®Google Scholar
• L'Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Cossetti C, D'Adamo P, Zardini E, Andreoni L, Ihekwaba AE, et al. Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Neurobiol. Dis. 2011; 41(2):508-27; http://dx.doi.org/10.1016/j.nbd.2010.10.023
   PubMed Web of Science ®Google Scholar
• L'Episcopo F, Tirolo C, Caniglia S, Testa N, Morale MC, Serapide MF, Pluchino S, Marchetti B. Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease. J. Mol. Cell Biol. 2014; 6(1):13-26; http://dx.doi.org/10.1093/jmcb/mjt053
   PubMed Web of Science ®Google Scholar
• Duka T, Duka V, Joyce JN, Sidhu A. Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models. FASEB J. 2009; 23(9):2820-30; PMID:19369384; http://dx.doi.org/10.1096/fj.08-120410
   PubMed Web of Science ®Google Scholar
• Kwok JBJ, Hallupp M, Loy CT, Chan DK, Woo J, Mellick GD, Buchanan DD, Silburn PA, Halliday GM, Schofield PR. GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. Ann. Neurol. 2005; 58(6):829-39; PMID:16315267; http://dx.doi.org/10.1002/ana.20691
   PubMed Web of Science ®Google Scholar
• Fancy SPJ, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 2009; 23(13):1571-85; PMID:19515974; http://dx.doi.org/10.1101/gad.1806309
   PubMed Web of Science ®Google Scholar
• Yu S, Levi L, Siegel R, Noy N. Retinoic acid induces neurogenesis by activating both retinoic acid receptors (RARs) and peroxisome proliferator-activated receptor β/δ (PPARβ/δ). J. Biol. Chem. 2012; 287(50):42195-205; PMID:23105114; http://dx.doi.org/10.1074/jbc.M112.410381
   PubMed Web of Science ®Google Scholar
• Dmetrichuk JM, Carlone RL, Spencer GE. Retinoic acid induces neurite outgrowth and growth cone turning in invertebrate neurons. Dev. Biol. 2006; 294(1):39-49; PMID:16626686; http://dx.doi.org/10.1016/j.ydbio.2006.02.018
   PubMed Web of Science ®Google Scholar
• Jacobs S, Lie DC, DeCicco KL, Shi Y, DeLuca LM, Gage FH, Evans RM. Retinoic acid is required early during adult neurogenesis in the dentate gyrus. Proc. Natl. Acad. Sci. U. S. A. 2006; 103(10):3902-7; PMID:16505366; http://dx.doi.org/10.1073/pnas.0511294103
   PubMed Web of Science ®Google Scholar
• Mizee MR, Wooldrik D, Lakeman KAM, van het Hof B, Drexhage JA, Geerts D, Bugiani M, Aronica E, Mebius RE, Prat A, et al. Retinoic acid induces blood-brain barrier development. J. Neurosci. 2013; 33(4):1660-71; PMID:23345238; http://dx.doi.org/10.1523/JNEUROSCI.1338-12.2013
   PubMed Web of Science ®Google Scholar
• Lippmann ES, Al-Ahmad A, Azarin SM, Palecek SP, Shusta EV. A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci. Rep. 2014; 4:4160; PMID:24561821; http://dx.doi.org/10.1038/srep04160
   PubMed Web of Science ®Google Scholar
• Jiménez-Jiménez FJ, Molina JA, de Bustos F, Ortí-Pareja M, Benito-León J, Tallón-Barranco A, Gasalla T, Porta J, Arenas J. Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease. Eur. J. Neurol. 1999; 6(4):495-7; http://dx.doi.org/10.1046/j.1468-1331.1999.640495.x
   PubMed Web of Science ®Google Scholar
• Connor MJ, Sidell N. Retinoic acid synthesis in normal and Alzheimer diseased brain and human neural cells. Mol. Chem. Neuropathol. 1997; 30(3):239-52; PMID:9165489; http://dx.doi.org/10.1007/BF02815101
   PubMedGoogle Scholar
• Ding Y, Qiao A, Wang Z, Goodwin JS, Lee ES, Block ML, Allsbrook M, McDonald MP, Fan GH. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J. Neurosci. 2008; 28(45):11622-34; PMID:18987198; http://dx.doi.org/10.1523/JNEUROSCI.3153-08.2008
   PubMed Web of Science ®Google Scholar
• Goncalves MB, Clarke E, Hobbs C, Malmqvist T, Deacon R, Jack J, Corcoran JP. Amyloid β inhibits retinoic acid synthesis exacerbating Alzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist. Eur. J. Neurosci. 2013; 37(7):1182-92; PMID:23379615; http://dx.doi.org/10.1111/ejn.12142
   PubMed Web of Science ®Google Scholar
• Takeda A, Nyssen OP, Syed A, Jansen E, Bueno-de-Mesquita B, Gallo V. Vitamin A and carotenoids and the risk of Parkinson's disease: a systematic review and meta-analysis. Neuroepidemiology 2014; 42(1):25-38; PMID:24356061; http://dx.doi.org/10.1159/000355849
   PubMed Web of Science ®Google Scholar
• Yin L-H, Shen H, Diaz-Ruiz O, Bäckman CM, Bae E, Yu SJ, Wang Y. Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease. BMC Neurosci. 2012; 13(1):120; PMID:23040108; http://dx.doi.org/10.1186/1471-2202-13-120
   PubMed Web of Science ®Google Scholar
• Ulusoy GK, Celik T, Kayir H, Gürsoy M, Isik AT, Uzbay TI. Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease. Brain Res. Bull. 2011; 85(6):380-4; PMID:21600965; http://dx.doi.org/10.1016/j.brainresbull.2011.05.001
   PubMed Web of Science ®Google Scholar
• Mizee MR, Nijland PG, van der Pol SMA, Drexhage JA, van Het Hof B, Mebius R, van der Valk P, van Horssen J, Reijerkerk A, de Vries HE. Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis. Acta Neuropathol. 2014; 128(5):691-703; PMID:25149081; http://dx.doi.org/10.1007/s00401-014-1335-6
   PubMed Web of Science ®Google Scholar
• Abtahi Froushani SM, Delirezh N, Hobbenaghi R, Mosayebi G. Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis. Immunol. Invest. 2014; 43(1):54-68; PMID:24063549; http://dx.doi.org/10.3109/08820139.2013.825269
   PubMed Web of Science ®Google Scholar
• Fragoso YD, Stoney PN, McCaffery PJ. The evidence for a beneficial role of vitamin A in multiple sclerosis. CNS Drugs 2014; 28(4):291-9; PMID:24557746; http://dx.doi.org/10.1007/s40263-014-0148-4
   PubMed Web of Science ®Google Scholar
• Massagué J. TGF-beta signal transduction. Annu. Rev. Biochem. 1998; 67:753-91; http://dx.doi.org/10.1146/annurev.biochem.67.1.753
   PubMed Web of Science ®Google Scholar
• McCormack N, O'Dea S. Regulation of epithelial to mesenchymal transition by bone morphogenetic proteins. Cell. Signal. 2013; 25(12):2856-62; PMID:24044921; http://dx.doi.org/10.1016/j.cellsig.2013.09.012
   PubMed Web of Science ®Google Scholar
• Mattar P, Cayouette M. Temporal control of neural progenitors: TGF-β switches the clock forward. Neuron 2014; 84(5):885-8; PMID:25475182; http://dx.doi.org/10.1016/j.neuron.2014.11.013
   PubMed Web of Science ®Google Scholar
• Stipursky J, Francis D, Dezonne RS, Bérgamo de Araújo AP, Souza L, Moraes CA, Alcantara Gomes FC. TGF-β1 promotes cerebral cortex radial glia-astrocyte differentiation in vivo. Front. Cell. Neurosci. 2014; 8:393; PMID:25484855; http://dx.doi.org/10.3389/fncel.2014.00393
   PubMed Web of Science ®Google Scholar
• Perrella MA, Jain MK, Lee ME. Role of TGF-beta in vascular development and vascular reactivity. Miner. Electrolyte Metab. 1998; 24(2-3):136-43; PMID:9525696; http://dx.doi.org/10.1159/000057361
   PubMedGoogle Scholar
• Flanders KC, Ren RF, Lippa CF. Transforming growth factor-betas in neurodegenerative disease. Prog. Neurobiol. 1998; 54(1):71-85; PMID:9460794; http://dx.doi.org/10.1016/S0301-0082(97)00066-X
   PubMed Web of Science ®Google Scholar
• Dohgu S, Yamauchi A, Takata F, Naito M, Tsuruo T, Higuchi S, Sawada Y, Kataoka Y. Transforming Growth Factor- 1 Upregulates the Tight Junction and P-glycoprotein of Brain Microvascular Endothelial Cells. Cell. Mol. Neurobiol. 2004; 24(3):491-497; PMID:15206827; http://dx.doi.org/10.1023/B:CEMN.0000022776.47302.ce
   PubMed Web of Science ®Google Scholar
• Dohgu S, Takata F, Yamauchi A, Nakagawa S, Egawa T, Naito M, Tsuruo T, Sawada Y, Niwa M, Kataoka Y. Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production. Brain Res. 2005; 1038(2):208-15; PMID:15757636; http://dx.doi.org/10.1016/j.brainres.2005.01.027
   PubMed Web of Science ®Google Scholar
• Seo JH, Maki T, Maeda M, Miyamoto N, Liang AC, Hayakawa K, Pham LD, Suwa F, Taguchi A, Matsuyama T, et al. Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-β signaling. PLoS One 2014; 9(7):e103174; PMID:25078775; http://dx.doi.org/10.1371/journal.pone.0103174
   PubMed Web of Science ®Google Scholar
• Flanders KC, Lippa CF, Smith TW, Pollen DA, Sporn MB. Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology 1995; 45(8):1561-9; PMID:7543987; http://dx.doi.org/10.1212/WNL.45.8.1561
   PubMed Web of Science ®Google Scholar
• De Servi B, La Porta CAM, Bontempelli M, Comolli R. Decrease of TGF-β1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease. Exp. Gerontol. 2002; 37(6):813-821; PMID:12175481; http://dx.doi.org/10.1016/S0531-5565(02)00018-9
   PubMed Web of Science ®Google Scholar
• Tesseur I, Zou K, Esposito L, Bard F, Berber E, Can JV, Lin AH, Crews L, Tremblay P, Mathews P, et al. Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. J. Clin. Invest. 2006; 116(11):3060-9; PMID:17080199; http://dx.doi.org/10.1172/JCI27341
   PubMed Web of Science ®Google Scholar
• Mogi M, Harada M, Kondo T, Narabayashi H, Riederer P, Nagatsu T. Transforming growth factor-β1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease. Neurosci. Lett. 1995; 193(2):129-132; PMID:7478158; http://dx.doi.org/10.1016/0304-3940(95)11686-Q
   PubMed Web of Science ®Google Scholar
• Qian L, Wei S-J, Zhang D, Hu X, Xu Z, Wilson B, El-Benna J, Hong JS, Flood PM. Potent Anti-Inflammatory and Neuroprotective Effects of TGF- 1 Are Mediated through the Inhibition of ERK and p47phox-Ser345 Phosphorylation and Translocation in Microglia. J. Immunol. 2008; 181(1):660-668; PMID:18566433; http://dx.doi.org/10.4049/jimmunol.181.1.660
   PubMed Web of Science ®Google Scholar
• Nicoletti F, Di Marco R, Patti F, Reggio E, Nicoletti A, Zaccone P, Stivala F, Meroni PL, Reggio A. Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b). Clin. Exp. Immunol. 1998; 113(1):96-9; PMID:9697990; http://dx.doi.org/10.1046/j.1365-2249.1998.00604.x
   PubMed Web of Science ®Google Scholar
• Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor beta 1. J. Immunol. 1991; 146(9):3012-3017; PMID:1707929
   PubMed Web of Science ®Google Scholar
• Liu A, Niswander LA. Bone morphogenetic protein signalling and vertebrate nervous system development. Nat. Rev. Neurosci. 2005; 6(12):945-54; PMID:16340955; http://dx.doi.org/10.1038/nrn1805
   PubMed Web of Science ®Google Scholar
• Xie Z, Sheng N, Jing N. BMP signaling pathway and spinal cord development. Front. Biol. (Beijing). 2012; 7(1):24-29
   Google Scholar
• Araya R, Kudo M, Kawano M, Ishii K, Hashikawa T, Iwasato T, Itohara S, Terasaki T, Oohira A, Mishina Y, et al. BMP signaling through BMPRIA in astrocytes is essential for proper cerebral angiogenesis and formation of the blood-brain-barrier. Mol. Cell. Neurosci. 2008; 38(3):417-30; PMID:18501628; http://dx.doi.org/10.1016/j.mcn.2008.04.003
   PubMed Web of Science ®Google Scholar
• Crews L, Adame A, Patrick C, Delaney A, Pham E, Rockenstein E, Hansen L, Masliah E. Increased BMP6 levels in the brains of Alzheimer's disease patients and APP transgenic mice are accompanied by impaired neurogenesis. J. Neurosci. 2010; 30(37):12252-62; PMID:20844121; http://dx.doi.org/10.1523/JNEUROSCI.1305-10.2010
   PubMed Web of Science ®Google Scholar
• Li D, Tang J, Xu H, Fan X, Bai Y, Yang L. Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1DeltaE9 mouse model of Alzheimer's disease. Hippocampus 2008; 18(7):692-8; PMID:18398851; http://dx.doi.org/10.1002/hipo.20428
   PubMed Web of Science ®Google Scholar
• Tang J, Song M, Wang Y, Fan X, Xu H, Bai Y. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease. Biochem. Biophys. Res. Commun. 2009; 385(3):341-5; PMID:19463786; http://dx.doi.org/10.1016/j.bbrc.2009.05.067
   PubMed Web of Science ®Google Scholar
• Harvey BK, Mark A, Chou J, Chen GJ, Hoffer BJ, Wang Y. Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease. Brain Res. 2004; 1022(1-2):88-95; PMID:15353217; http://dx.doi.org/10.1016/j.brainres.2004.06.072
   PubMed Web of Science ®Google Scholar
• Stull ND, Jung JW, Iacovitti L. Induction of a dopaminergic phenotype in cultured striatal neurons by bone morphogenetic proteins. Dev. Brain Res. 2001; 130(1):91-98; http://dx.doi.org/10.1016/S0165-3806(01)00216-4
   PubMedGoogle Scholar
• Brederlau A. Bone Morphogenetic Proteins but Not Growth Differentiation Factors Induce Dopaminergic Differentiation in Mesencephalic Precursors. Mol. Cell. Neurosci. 2002; 21(3):367-378; PMID:12498780; http://dx.doi.org/10.1006/mcne.2002.1178
   PubMed Web of Science ®Google Scholar
• Ara J, See J, Mamontov P, Hahn A, Bannerman P, Pleasure D, Grinspan JB. Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis. J. Neurosci. Res. 2008; 86(1):125-35; PMID:17722066; http://dx.doi.org/10.1002/jnr.21462
   PubMed Web of Science ®Google Scholar
• Deininger M, Meyermann R, Schluesener H. Detection of two transforming growth factor-beta-related morphogens, bone morphogenetic proteins-4 and -5, in RNA of multiple sclerosis and Creutzfeldt-Jakob disease lesions. Acta Neuropathol. 1995; 90(1):76-9; PMID:7572083; http://dx.doi.org/10.1007/BF00294462
   PubMed Web of Science ®Google Scholar
• Sabo JK, Aumann TD, Merlo D, Kilpatrick TJ, Cate HS. Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions. J. Neurosci. 2011; 31(12):4504-10; PMID:21430151; http://dx.doi.org/10.1523/JNEUROSCI.5859-10.2011
   PubMed Web of Science ®Google Scholar
• Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87(7):1171-80; PMID:8980224; http://dx.doi.org/10.1016/S0092-8674(00)81813-9
   PubMed Web of Science ®Google Scholar
• Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277(5322):55-60; PMID:9204896; http://dx.doi.org/10.1126/science.277.5322.55
   PubMed Web of Science ®Google Scholar
• Lee HJ, Cho C-H, Hwang S-J, Choi HH, Kim KT, Ahn SY, Kim JH, Oh JL, Lee GM, Koh GY. Biological characterization of angiopoietin-3 and angiopoietin-4. FASEB J. 2004; 18(11):1200-8; PMID:15284220; http://dx.doi.org/10.1096/fj.03-1466com
   PubMed Web of Science ®Google Scholar
• Meng Z, Li M, He Q, Jiang S, Zhang X, Xiao J, Bai Y. Ectopic expression of human angiopoietin-1 promotes functional recovery and neurogenesis after focal cerebral ischemia. Neuroscience 2014; 267:135-46; PMID:24607344; http://dx.doi.org/10.1016/j.neuroscience.2014.02.036
   PubMed Web of Science ®Google Scholar
• Marteau L, Pacary E, Valable S, Bernaudin M, Guillemot F, Petit E. Angiopoietin-2 regulates cortical neurogenesis in the developing telencephalon. Cereb. Cortex 2011; 21(7):1695-702; http://dx.doi.org/10.1093/cercor/bhq243
   Web of Science ®Google Scholar
• Thurston G. Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1. Science (80-. ). 1999; 286(5449):2511-2514; http://dx.doi.org/10.1126/science.286.5449.2511
   PubMed Web of Science ®Google Scholar
• Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 2000; 6(4):460-3; PMID:10742156; http://dx.doi.org/10.1038/74725
   PubMed Web of Science ®Google Scholar
• Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, Goussev A, Powers C, Yeich T, Chopp M. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2002; 22(4):379-92; PMID:11919509; http://dx.doi.org/10.1097/00004647-200204000-00002
   PubMed Web of Science ®Google Scholar
• Nourhaghighi N, Teichert-Kuliszewska K, Davis J, Stewart DJ, Nag S. Altered Expression of Angiopoietins During Blood-Brain Barrier Breakdown and Angiogenesis. Lab. Investig. 2003; 83(8):1211-1222; http://dx.doi.org/10.1097/01.LAB.0000082383.40635.FE
   PubMed Web of Science ®Google Scholar
• Yu H, Wang P, An P, Xue Y, Yixue X. Recombinant human angiopoietin-1 ameliorates the expressions of ZO-1, occludin, VE-cadherin, and PKCα signaling after focal cerebral ischemia/reperfusion in rats. J. Mol. Neurosci. 2012; 46(1):236-47; PMID:21710361; http://dx.doi.org/10.1007/s12031-011-9584-5
   PubMed Web of Science ®Google Scholar
• Zhao Y, Li Z, Wang R, Wei J, Li G, Zhao H. Angiopoietin 1 counteracts vascular endothelial growth factor-induced blood-brain barrier permeability and alleviates ischemic injury in the early stages of transient focal cerebral ischemia in rats. Neurol. Res. 2010; 32(7):748-55; PMID:19660197; http://dx.doi.org/10.1179/016164109X12445616596562
   PubMed Web of Science ®Google Scholar
• Avraham HK, Jiang S, Fu Y, Nakshatri H, Ovadia H, Avraham S. Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain. J. Pathol. 2014; 232(3):369-81; PMID:24421076; http://dx.doi.org/10.1002/path.4304
   PubMed Web of Science ®Google Scholar
• Lai D-M, Li H, Lee C-C, Tzeng YS, Hsieh YH, Hsu WM, Hsieh FJ, Cheng JT, Tu YK. Angiopoietin-like protein 1 decreases blood brain barrier damage and edema following focal cerebral ischemia in mice. Neurochem. Int. 2008; 52(3):470-7; PMID:17919782; http://dx.doi.org/10.1016/j.neuint.2007.08.010
   PubMed Web of Science ®Google Scholar
• Bouleti C, Mathivet T, Coqueran B, Serfaty JM, Lesage M, Berland E, Ardidie-Robouant C, Kauffenstein G, Henrion D, Lapergue B, et al. Protective effects of angiopoietin-like 4 on cerebrovascular and functional damages in ischaemic stroke. Eur. Heart J. 2013; 34(47):3657-68; PMID:23674618; http://dx.doi.org/10.1093/eurheartj/eht153
   PubMed Web of Science ®Google Scholar
• Thirumangalakudi L, Samany PG, Owoso A, Wiskar B, Grammas P. Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J. Alzheimers. Dis. 2006; 10(1):111-8; PMID:16988487
   PubMed Web of Science ®Google Scholar
• Paris D, Townsend K, Quadros A, Humphrey J, Sun J, Brem S, Wotoczek-Obadia M, DelleDonne A, Patel N, Obregon DF, et al. Inhibition of angiogenesis by Abeta peptides. Angiogenesis 2004; 7(1):75-85; PMID:15302999; http://dx.doi.org/10.1023/B:AGEN.0000037335.17717.bf
   PubMedGoogle Scholar
• Sillén A, Brohede J, Lilius L, Forsell C, Andrade J, Odeberg J, Ebise H, Winblad B, Graff C. Linkage to 20p13 including the ANGPT4 gene in families with mixed Alzheimer's disease and vascular dementia. J. Hum. Genet. 2010; 55(10):649-55; http://dx.doi.org/10.1038/jhg.2010.79
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhang F, Yang J, Han S. Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis. Exp. Neurol. 2014; 261:245-57; PMID:24852101; http://dx.doi.org/10.1016/j.expneurol.2014.05.013
   PubMed Web of Science ®Google Scholar
• Luo Y, Raible D, Raper JA. Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 1993; 75(2):217-27; PMID:8402908; http://dx.doi.org/10.1016/0092-8674(93)80064-L
   PubMed Web of Science ®Google Scholar
• Unified nomenclature for the semaphorins/collapsins. Semaphorin Nomenclature Committee. Cell 1999; 97(5):551-2; PMID:10367884; http://dx.doi.org/10.1016/S0092-8674(00)80766-7
   PubMed Web of Science ®Google Scholar
• Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H, Chedotal A, Winberg ML, Goodman CS, Poo M, et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999; 99(1):71-80; PMID:10520995; http://dx.doi.org/10.1016/S0092-8674(00)80063-X
   PubMed Web of Science ®Google Scholar
• He Z, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 1997; 90(4):739-51; PMID:9288753; http://dx.doi.org/10.1016/S0092-8674(00)80534-6
   PubMed Web of Science ®Google Scholar
• Koncina E, Roth L, Gonthier B, Bagnard D. Role of Semaphorins during Axon Growth and Guidance. Adv Exp Med Biol 621:50-64
   Google Scholar
• Bagnard D, Lohrum M, Uziel D, Püschel AW, Bolz J. Semaphorins act as attractive and repulsive guidance signals during the development of cortical projections. Development 1998; 125(24):5043-53; PMID:9811588
   PubMed Web of Science ®Google Scholar
• De Castro F, Hu L, Drabkin H, Sotelo C, Chédotal A. Chemoattraction and chemorepulsion of olfactory bulb axons by different secreted semaphorins. J. Neurosci. 1999; 19(11):4428-36; PMID:10341244
   PubMed Web of Science ®Google Scholar
• Serini G, Valdembri D, Zanivan S, Morterra G, Burkhardt C, Caccavari F, Zammataro L, Primo L, Tamagnone L, Logan M, et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 2003; 424(6947):391-7; PMID:12879061; http://dx.doi.org/10.1038/nature01784
   PubMed Web of Science ®Google Scholar
• Suzuki K, Kumanogoh A, Kikutani H. Semaphorins and their receptors in immune cell interactions. Nat. Immunol. 2008; 9(1):17-23; PMID:18087252; http://dx.doi.org/10.1038/ni1553
   PubMed Web of Science ®Google Scholar
• Acevedo LM, Barillas S, Weis SM, Göthert JR, Cheresh DA. Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 2008; 111(5):2674-80; PMID:18180379; http://dx.doi.org/10.1182/blood-2007-08-110205
   PubMed Web of Science ®Google Scholar
• Le Guelte A, Galan-Moya E-M, Dwyer J, Treps L, Kettler G, Hebda JK, Dubois S, Auffray C, Chneiweiss H, Bidere N, et al. Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation. J. Cell Sci. 2012; 125(Pt 17):4137-46; PMID:22685328; http://dx.doi.org/10.1242/jcs.108282
   PubMed Web of Science ®Google Scholar
• Smith ES, Jonason A, Reilly C, Veeraraghavan J, Fisher T, Doherty M, Klimatcheva E, Mallow C, Cornelius C, Leonard JE, et al. SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease. Neurobiol. Dis. 2015; 73:254-268; http://dx.doi.org/10.1016/j.nbd.2014.10.008
   PubMed Web of Science ®Google Scholar
• Good PF, Alapat D, Hsu A, Chu C, Perl D, Wen X, Burstein DE, Kohtz DS. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease. J. Neurochem. 2004; 91(3):716-36; PMID:15485501; http://dx.doi.org/10.1111/j.1471-4159.2004.02766.x
   PubMed Web of Science ®Google Scholar
• Jun G, Asai H, Zeldich E, Drapeau E, Chen C, Chung J, Park JH, Kim S, Haroutunian V, Foroud T, et al. PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation. Ann. Neurol. 2014; 76(3):379-92; PMID:25043464; http://dx.doi.org/10.1002/ana.24219
   PubMed Web of Science ®Google Scholar
• Clarimon J, Scholz S, Fung H-C, Hardy J, Eerola J, Hellstrom O, Chen CM, Wu YR, Tienari PJ, Singleton A. Conflicting results regarding the semaphorin gene (SEMA5A) and the risk for Parkinson disease. Am. J. Hum. Genet. 2006; 78(6):1082-4; author reply 1092-4; PMID:16685660; http://dx.doi.org/10.1086/504727
   PubMed Web of Science ®Google Scholar
• Okuno T, Nakatsuji Y, Kumanogoh A. The role of immune semaphorins in multiple sclerosis. FEBS Lett. 2011; 585(23):3829-35; PMID:21420960; http://dx.doi.org/10.1016/j.febslet.2011.03.033
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Molecular Trojan horses for blood-brain barrier drug delivery. Curr. Opin. Pharmacol. 2006; 6(5):494-500; PMID:16839816; http://dx.doi.org/10.1016/j.coph.2006.06.001
   PubMed Web of Science ®Google Scholar
• Peluffo H, Unzueta U, Negro-Demontel ML, Xu Z, Váquez E, Ferrer-Miralles N, Villaverde A. BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS. Biotechnol. Adv. 33(2):277-87; PMID:25698504; http://dx.doi.org/10.1016/j.biotechadv.2015.02.004
   PubMed Web of Science ®Google Scholar
• Southwell AL, Franciosi S, Villanueva EB, Xie Y, Winter LA, Veeraraghavan J, Jonason A, Felczak B, Zhang W, Kovalik V, et al. Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease. Neurobiol. Dis. 2015; 76:46-56; PMID:25662335; http://dx.doi.org/10.1016/j.nbd.2015.01.002
   PubMed Web of Science ®Google Scholar
• Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425(6958):577-84; PMID:14534577; http://dx.doi.org/10.1038/nature02006
   PubMed Web of Science ®Google Scholar
• Pendaries V, Verrecchia F, Michel S, Mauviel A. Retinoic acid receptors interfere with the TGF-beta/Smad signaling pathway in a ligand-specific manner. Oncogene 2003; 22(50):8212-20; PMID:14603262; http://dx.doi.org/10.1038/sj.onc.1206913
   PubMed Web of Science ®Google Scholar
• Sheng N, Xie Z, Wang C, Bai G, Zhang K, Zhu Q, Song J, Guillemot F, Chen YG, Lin A, et al. Retinoic acid regulates bone morphogenic protein signal duration by promoting the degradation of phosphorylated Smad1. Proc. Natl. Acad. Sci. U. S. A. 2010; 107(44):18886-91; PMID:20956305; http://dx.doi.org/10.1073/pnas.1009244107
   PubMed Web of Science ®Google Scholar
• Guo X, Wang X-F. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res. 2009; 19(1):71-88; PMID:19002158; http://dx.doi.org/10.1038/cr.2008.302
   PubMed Web of Science ®Google Scholar
• Kim W, Moon S-O, Lee SY, Jang KY, Cho CH, Koh GY, Choi KS, Yoon KH, Sung MJ, Kim DH, et al. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model. J. Am. Soc. Nephrol. 2006; 17(9):2474-83; PMID:16885409; http://dx.doi.org/10.1681/ASN.2006020109
   PubMed Web of Science ®Google Scholar
• Kim W. The role of angiopoietin-1 in kidney disease. Electrolyte Blood Press. 2008; 6(1):22-6.
   PubMedGoogle Scholar
• Nakamura T, Okada T, Endo M, Kadomatsu T, Taniwaki T, Sei A, Odagiri H, Masuda T, Fujimoto T, Nakamura T, et al. Angiopoietin-like protein 2 induced by mechanical stress accelerates degeneration and hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis. PLoS One 2014; 9(1):e85542; PMID:24465594; http://dx.doi.org/10.1371/journal.pone.0085542
   PubMed Web of Science ®Google Scholar
• Glinka Y, Prud'homme GJ. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J. Leukoc. Biol. 2008; 84(1):302-10; PMID:18436584; http://dx.doi.org/10.1189/jlb.0208090
   PubMed Web of Science ®Google Scholar
• Cao Y, Szabolcs A, Dutta SK, Yaqoob U, Jagavelu K, Wang L, Leof EB, Urrutia RA, Shah VH, Mukhopadhyay D. Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype. J. Biol. Chem. 2010; 285(41):31840-8; PMID:20675371; http://dx.doi.org/10.1074/jbc.M110.151696
   PubMed Web of Science ®Google Scholar
• Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res. 2009; 19(1):128-39; PMID:19114990; http://dx.doi.org/10.1038/cr.2008.328
   PubMed Web of Science ®Google Scholar
• Yen A, Roberson MS, Varvayanis S, Lee AT. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 1998; 58(14):3163-72; PMID:9679985
   PubMed Web of Science ®Google Scholar
• Bikkavilli RK, Malbon CC. Mitogen-activated protein kinases and Wnt/beta-catenin signaling: Molecular conversations among signaling pathways. Commun. Integr. Biol. 2009; 2(1):46-9; PMID:19513264; http://dx.doi.org/10.4161/cib.2.1.7503
   PubMedGoogle Scholar
• Guardavaccaro D, Clevers H. Wnt/β-catenin and MAPK signaling: allies and enemies in different battlefields. Sci. Signal. 2012; 5(219):pe15; PMID:22494969; http://dx.doi.org/10.1126/scisignal.2002921
   PubMed Web of Science ®Google Scholar
• Elia D, Madhala D, Ardon E, Reshef R, Halevy O. Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: Involvement of MAPK/ERK and PI3K/Akt pathways. Biochim. Biophys. Acta 2007; 1773(9):1438-46
   Google Scholar
• Kessaris N, Jamen F, Rubin LL, Richardson WD. Cooperation between sonic hedgehog and fibroblast growth factor/MAPK signalling pathways in neocortical precursors. Development 2004; 131(6):1289-98; PMID:14960493; http://dx.doi.org/10.1242/dev.01027
   PubMed Web of Science ®Google Scholar
• Zhu W-H, MacIntyre A, Nicosia RF. Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting. Am. J. Pathol. 2002; 161(3):823-30; PMID:12213710; http://dx.doi.org/10.1016/S0002-9440(10)64242-3
   PubMed Web of Science ®Google Scholar
• Hashiramoto A, Sakai C, Yoshida K, Tsumiyama K, Miura Y, Shiozawa K, Nose M, Komai K, Shiozawa S. Angiopoietin 1 directly induces destruction of the rheumatoid joint by cooperative, but independent, signaling via ERK/MAPK and phosphatidylinositol 3-kinase/Akt. Arthritis Rheum. 2007; 56(7):2170-9; PMID:17599743; http://dx.doi.org/10.1002/art.22727
   PubMed Web of Science ®Google Scholar
• Li Y, Chen J, Wu C, Wang L, Lu M, Chen X. Hepatitis B virus/hepatitis C virus upregulate angiopoietin-2 expression through mitogen-activated protein kinase pathway. Hepatol. Res. 2010; 40(10):1022-33; PMID:20887338; http://dx.doi.org/10.1111/j.1872-034X.2010.00712.x
   PubMed Web of Science ®Google Scholar
• He D-K, Shao Y-R, Zhang L, Shen J, Zhong ZY, Wang J, Xu G. Adenovirus-delivered angiopoietin-1 suppresses NF-κB and p38 MAPK and attenuates inflammatory responses in phosgene-induced acute lung injury. Inhal. Toxicol. 2014; 26(3):185-92; PMID:24517841; http://dx.doi.org/10.3109/08958378.2013.872213
   PubMed Web of Science ®Google Scholar
• Aurandt J, Li W, Guan K-L. Semaphorin 4D activates the MAPK pathway downstream of plexin-B1. Biochem. J. 2006; 394(Pt 2):459-64; PMID:16187944; http://dx.doi.org/10.1042/BJ20051123
   PubMed Web of Science ®Google Scholar
• Pasterkamp RJ, Peschon JJ, Spriggs MK, Kolodkin AL. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 2003; 424(6947):398-405; PMID:12879062; http://dx.doi.org/10.1038/nature01790
   PubMed Web of Science ®Google Scholar
• López-Carballo G, Moreno L, Masiá S, Pérez P, Barettino D. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J. Biol. Chem. 2002; 277(28):25297-304; http://dx.doi.org/10.1074/jbc.M201869200
   PubMed Web of Science ®Google Scholar
• Ohashi E, Kogai T, Kagechika H, Brent GA. Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells. Cancer Res. 2009; 69(8):3443-50; PMID:19351850; http://dx.doi.org/10.1158/0008-5472.CAN-08-3234
   PubMed Web of Science ®Google Scholar
• Roolf C, Krohn S, Kretzschmar C, et al. PI3K/Akt Signaling Interacts With Wnt/β-Catenin Signaling But Does Not Induce An Accumulation Of β-Catenin In The Nucleus Of Acute Lymphoblastic Leukemia Cell Lines. Blood 2013; 122(21):4886
   Web of Science ®Google Scholar
• Riobó NA, Lu K, Ai X, Haines GM, Emerson CP. Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proc. Natl. Acad. Sci. U. S. A. 2006; 103(12):4505-10; http://dx.doi.org/10.1073/pnas.0504337103
   PubMed Web of Science ®Google Scholar
• Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ. Res. 86(1):24-9; PMID:10625301; http://dx.doi.org/10.1161/01.RES.86.1.24
   PubMed Web of Science ®Google Scholar
• Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol. Cell. Biol. 2009; 29(8):2011-22; PMID:19223473; http://dx.doi.org/10.1128/MCB.01472-08
   PubMed Web of Science ®Google Scholar
• Pasterkamp RJ. Semaphorins: receptor and intracellular mechanisms. Adv. Exp. Med. Biol. 2007; 600:38-51; PMID:17607945; http://dx.doi.org/10.1007/978-0-387-70956-7
   PubMed Web of Science ®Google Scholar